Saluda Medical earned FDA approval for its biomarker-based automated patient programming platform used in spinal cord stimulation.

As technology continues to advance, so too does the possibility of better outcomes in spine surgery. 

Centinel Spine saw prodisc revenue surpass $95 million in 2024, according to a Jan. 23 news release.

Aurora Spine promoted two executive leaders, the spine devicemaker said Jan. 22.

From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.

Medical device manufacturer Osteotec has reached an exclusive distribution agreement with Highridge Medical in the U.K. 

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

SI-BONE (NASDAQ: SIBN) has introduced an advanced posteromedial technique for its iFuse TORQ® Implant System, expanding its suite of minimally invasive solutions for treating sacroiliac joint (SIJ) dysfunction. Developed in partnership with Dr. Babajide Ogunseinde from Longview, Texas, the posteromedial technique offers a streamlined approach to treating SIJ dysfunction that enables surgeons to address both SI joints through a single midline incision, with one surgical position. This innovation aims to improve efficiency in the operating room by simplifying the procedure for spine surgeons and interventional spine specialists.

Medical devicemaker Medtronic has appointed Thierry Piéton as CFO.

Here are seven orthopedic and spine devices and technologies that have recently received FDA clearance, as reported by Becker's since Dec. 17:

From device clearances to mergers, here are five developments from spine and orthopedic devicemakers since Jan. 8.

Spine devicemaker icotec earned FDA 510(k) clearance for its BlackArmor spine implants, according to a Jan. 14 news release.

Saluda Medical closed a $100 million finance round, the spine company said Jan. 10.

Onward Medical's Arc-EX spinal cord stimulator saw its first U.S. sales in late December, according to a Jan. 9 news release.

From new partnerships to acquisitions, here are four key developments from spine and orthopedic medtech companies since Jan. 1.

Stryker has entered a definitive agreement to acquire medical device company Inari Medical for approximately $4.9 billion. 

SpineGuard and Omnia Medical extended their partnership and have their eyes on U.S. market growth, according to a Jan. 6 news release. 

L&K Spine Inc. is thrilled to announce a landmark achievement in the field of spinal surgery with the 3,000th successful level implantation of its flagship product as of December 27, 2024, the PathLoc-TM PLIF/TLIF Expandable Cage. This cutting-edge spinal implant represents a transformative advancement in personalized surgical solutions for spinal disorders, offering unparalleled adaptability and precision.

Here are five updates to know on medtech company Stryker that Becker's reported on during the fourth quarter:

Onward's Arc-Ex spinal cord stimulator earned the FDA's de novo classification and U.S. market authorization, according to a Dec. 19 news release.